Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127116891 | 12711689 | 1 | I | 20160318 | 20160829 | 20160902 | 20160902 | EXP | FR-009507513-1608FRA015424 | MERCK | 85.07 | YR | M | Y | 0.00000 | 20160902 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127116891 | 12711689 | 1 | PS | VIRAFERONPEG | PEGINTERFERON ALFA-2B | 1 | UNK | 103949 | POWDER FOR INJECTION | ||||||||||
| 127116891 | 12711689 | 2 | SS | REBETOL | RIBAVIRIN | 1 | Oral | UNK | 0 | CAPSULE | |||||||||
| 127116891 | 12711689 | 3 | C | APROVEL | IRBESARTAN | 1 | 300 MG, QD | 0 | 300 | MG | QD | ||||||||
| 127116891 | 12711689 | 4 | C | LASILIX | FUROSEMIDE | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 127116891 | 12711689 | 5 | C | DELURSAN | URSODIOL | 1 | 500 MG, BID | 0 | 500 | MG | BID | ||||||||
| 127116891 | 12711689 | 6 | C | HYPERIUM | RILMENIDINE PHOSPHATE | 1 | 1 MG, BID | 0 | 1 | MG | BID | ||||||||
| 127116891 | 12711689 | 7 | C | ALDACTONE | SPIRONOLACTONE | 1 | 25 MG, QD | 0 | 25 | MG | QD | ||||||||
| 127116891 | 12711689 | 8 | C | TEMERIT | NEBIVOLOL | 1 | 5 MG, QD | 0 | 5 | MG | QD | ||||||||
| 127116891 | 12711689 | 9 | C | COUMADIN | WARFARIN SODIUM | 1 | UNK, QD | 0 | QD | ||||||||||
| 127116891 | 12711689 | 10 | C | EUPANTOL | PANTOPRAZOLE SODIUM | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 127116891 | 12711689 | 11 | C | XATRAL | ALFUZOSIN | 1 | 10 MG, QD | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127116891 | 12711689 | 1 | Hepatitis C |
| 127116891 | 12711689 | 2 | Hepatitis C |
| 127116891 | 12711689 | 3 | Cardiomyopathy |
| 127116891 | 12711689 | 4 | Cardiomyopathy |
| 127116891 | 12711689 | 5 | Hepatic cirrhosis |
| 127116891 | 12711689 | 6 | Hypertension |
| 127116891 | 12711689 | 7 | Hypertension |
| 127116891 | 12711689 | 8 | Cardiomyopathy |
| 127116891 | 12711689 | 9 | Cardiomyopathy |
| 127116891 | 12711689 | 10 | Cardiomyopathy |
| 127116891 | 12711689 | 11 | Cardiomyopathy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127116891 | 12711689 | HO |
| 127116891 | 12711689 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127116891 | 12711689 | Hepatocellular carcinoma | |
| 127116891 | 12711689 | Metastases to lung | |
| 127116891 | 12711689 | Pancreatic disorder | |
| 127116891 | 12711689 | Portal vein thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127116891 | 12711689 | 1 | 20020423 | 20021030 | 0 | |
| 127116891 | 12711689 | 2 | 20020423 | 20021015 | 0 | |
| 127116891 | 12711689 | 3 | 20131202 | 0 | ||
| 127116891 | 12711689 | 5 | 2016 | 0 | ||
| 127116891 | 12711689 | 6 | 2016 | 0 | ||
| 127116891 | 12711689 | 7 | 201402 | 0 | ||
| 127116891 | 12711689 | 8 | 20130612 | 0 | ||
| 127116891 | 12711689 | 9 | 2016 | 0 | ||
| 127116891 | 12711689 | 10 | 201402 | 0 |